Skip to main content
RENALYTIX PLC logo

RENALYTIX PLC — Investor Relations & Filings

Ticker · RENX ISIN · GB00BYWL4Y04 LEI · 213800NTOH3FK3WER551 IL Human health and social work activities
Open in API
Filings indexed 444 across all filing types
Latest filing 2025-12-16 Major Shareholding Noti…
Country GB United Kingdom
Listing IL RENX

About RENALYTIX PLC

https://renalytix.com/

Renalytix is a diagnostics company that develops artificial intelligence-enabled solutions for the clinical management of kidney disease. Its flagship product, KidneyIntelX.dkd™, is an FDA-authorized blood test for adults with type 2 diabetes and early-stage chronic kidney disease. The test utilizes a proprietary bioprognostic™ methodology to analyze biomarkers and clinical data, predicting the risk of a progressive decline in kidney function over a five-year period. This risk assessment enables clinicians to identify high-risk patients and implement targeted, guideline-recommended treatments to slow disease progression and improve outcomes.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings' filed by Renalytix PLC. It details a change in share ownership by UBS Group AG, crossing a reporting threshold. This is a classic regulatory disclosure regarding significant shareholding changes, which falls under the 'Major Shareholding Notification' category.
2025-12-16 English
Result of AGM
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement from Renalytix plc regarding the results of its Annual General Meeting (AGM). It explicitly lists the resolutions voted upon and the outcome of those votes (For, Against, Withheld). This falls directly under the category of Declaration of Voting Results & Voting Rights Announcements.
2025-12-09 English
AGM Statement
AGM Information Classification · 95% confidence The document is an 'AGM Statement' issued by Renalytix plc ahead of its Annual General Meeting. It provides a management update on business strategy, partnerships, and operational progress. While it is related to the AGM, it is a narrative statement provided by the Executive Chairman rather than the full set of meeting materials (like proxy cards or voting forms). According to the definitions, presentations and materials shared during the AGM are classified as AGM-R.
2025-12-09 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings' filed by Renalytix PLC. It details a change in share ownership by UBS Group AG, crossing a specific voting rights threshold. This type of regulatory disclosure regarding significant shareholding changes is classified as a Major Shareholding Notification (MRQ).
2025-11-27 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings' filed by Renalytix PLC. It explicitly details a change in shareholding percentage by UBS Group AG, which fell below the 5% threshold. This is a standard regulatory disclosure regarding major shareholding notifications, which corresponds to the 'Major Shareholding Notification' (MRQ) category.
2025-11-25 English
Plan to Implement ADS Ratio Change
Share Issue/Capital Change Classification · 100% confidence The document is an official announcement from Renalytix plc regarding a change in the ratio of its American Depository Shares (ADS). This is a corporate action involving capital structure and share mechanics. While it relates to shares, it is specifically a change in the ADS ratio (a reverse split-like mechanism), which falls under the category of capital changes or share structure updates. Given the specific options, 'SHA' (Share Issue/Capital Change) is the most accurate classification for an announcement regarding a change in share ratios.
2025-11-25 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.